|
Multiple sclerosis
Citations 181-190 of 469 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Disparities in the management of multiple sclerosis–related bladder symptoms
- R. A. Marrie, G. Cutter, T. Tyry, T. Vollmer, and D. Campagnolo
Neurology 2007; 68: 1971-1978.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
MITOXANTRONE FOR MULTIPLE SCLEROSIS CAUSING ACUTE LYMPHOBLASTIC LEUKEMIA
- M. S. Cartwright, D. R. Jeffery, Z. T. Lewis, P. P. Koty, W. T. Stewart, and I. Molnár
Neurology 2007; 68: 1630-1631.
[Full text]
[PDF]
- ARTICLES
Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS
- Jorge Sepulcre, Manuel Murie-Fernandez, Angel Salinas-Alaman, Alfredo García-Layana, Bartolome Bejarano, and Pablo Villoslada
Neurology 2007; 68: 1488-1494.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A population-based survey of multiple sclerosis in Shanghai, China
- Q. Cheng, L. Miao, J. Zhang, S. -J. Ding, Z. -G. Liu, X. Wang, X. -J. Sun, Z. -X. Zhao, Y. -J. Song, X. -Y. Ding, Z. -L. Guo, Y. Yang, S. -D. Chen, G. -X. Jiang, and S. Fredrikson
Neurology 2007; 68: 1495-1500.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis
- E. R. Dorsey, J. P. Thompson, K. Noyes, A. W. Dick, R. G. Holloway, and S. R. Schwid
Neurology 2007; 68: 1524-1528.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
- L. J. Balcer, S. L. Galetta, P. A. Calabresi, C. Confavreux, G. Giovannoni, E. Havrdova, M. Hutchinson, L. Kappos, F. D. Lublin, D. H. Miller, P. W. O'Connor, J. T. Phillips, C. H. Polman, E. -W. Radue, R. A. Rudick, W. H. Stuart, A. Wajgt, B. Weinstock-Guttman, D. R. Wynn, F. Lynn, M. A. Panzara for the AFFIRM and SENTINEL Investigators
Neurology 2007; 68: 1299-1304.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation
- M. P. Gorman, M. R. Golomb, L. E. Walsh, G. M. Hobson, J. Y. Garbern, R. P. Kinkel, B. T. Darras, D. K. Urion, and Y. Z. Eksioglu
Neurology 2007; 68: 1305-1307.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing–remitting MS
- J. A. Cohen, M. Rovaris, A. D. Goodman, D. Ladkani, D. Wynn, M. Filippi for the 9006 Study Group
Neurology 2007; 68: 939-944.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Multiple sclerosis: Relating MxA transcription to anti-interferon-ß-neutralizing antibodies
- L. A. Hoffmann, M. Krumbholz, H. Faber, T. Kuempfel, M. Starck, W. Pöllmann, E. Meinl, and R. Hohlfeld
Neurology 2007; 68: 958-959.
[Full text]
[PDF]
- ARTICLE
High CSF neurofilament heavy chain levels in neuromyelitis optica
- I. Miyazawa, I. Nakashima, A. Petzold, K. Fujihara, S. Sato, and Y. Itoyama
Neurology 2007; 68: 865-867.
[Abstract]
[Full text]
[PDF]
|
|
